TCI Wealth Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

TCI Wealth Advisors’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-290	Closed	-$4.48K	–	2408
2023 Q1	$4.48K	Buy	+290	New	+$4.84K	﹤0.01%	1603
2021 Q4	–	Sell	-90	Closed	-$3K	–	2575
2021 Q3	$3K	Buy	+90	New	+$2.87K	﹤0.01%	2054
2021 Q2	–	Sell	-46	Closed	-$2K	–	2489
2021 Q1	$2K	Buy	+46	New	+$2.14K	﹤0.01%	1953

Other funds holding DCPH

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TCI Wealth Advisors's DCPH Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2023, closing a stake of 290 shares — an estimated $4.48K sold.

TCI Wealth Advisors first reported a position in DCPH in Q1 2021 and held it in 3 quarters. The position peaked at $4.48K in Q1 2023. 145 funds tracked by Wall St. Rank hold DCPH as of Q2 2023.

TCI Wealth Advisors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
TCI Wealth Advisors sold 290 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $4.48K.
TCI Wealth Advisors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
TCI Wealth Advisors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $4.48K in Q1 2023.
145 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.